Why is Biocon falling/rising?

As of 17-Jul, Biocon Ltd. is experiencing a price increase, currently trading at Rs 396.60, which reflects a rise of 2.05 (0.52%). The stock has shown strong performance recently, gaining 6.61% over the past week and 12.49% over the past month, significantly outperforming the Sensex, which has declined by 1.12% in the same week and increased by only 0.83% over the month. The stock is also close to its 52-week high, just 2.33% away from Rs 405.85. Positive factors contributing to this upward movement include a high inventory turnover ratio and substantial growth in profit after tax, which has increased by 69% compared to the previous four-quarter average. Additionally, the stock is trading at a discount relative to its peers, and institutional holdings have risen, indicating confidence from larger investors.
In the broader market context, Biocon's recent performance stands out as it has generated a return of 12.14% over the past year, significantly higher than the BSE500's return of only 0.26%. This market-beating performance, combined with rising investor participation and liquidity, suggests a favorable sentiment towards the stock. However, it is important to note the risks associated with the company, such as a high Debt to EBITDA ratio and low long-term growth potential, which could impact future performance. Despite these concerns, the current momentum and positive financial indicators appear to be driving the stock's recent rise.